Zions Bancorporation’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-695
Closed -$15K 900
2019
Q4
$15K Buy
695
+656
+1,682% +$14.6K ﹤0.01% 655
2019
Q3
$1K Sell
39
-37
-49% -$844 ﹤0.01% 907
2019
Q2
$2K Sell
76
-10
-12% -$206 ﹤0.01% 801
2019
Q1
$1K Sell
86
-52
-38% -$910 ﹤0.01% 869
2018
Q4
$2K Sell
138
-30
-18% -$776 ﹤0.01% 410
2018
Q3
$7K Sell
168
-110
-40% -$4.96K ﹤0.01% 601
2018
Q2
$14K Sell
278
-79
-22% -$4.48K 0.01% 307
2018
Q1
$21K Sell
357
-141
-28% -$9.4K ﹤0.01% 340
2017
Q4
$39K Sell
498
-478
-49% -$38.6K 0.01% 351
2017
Q3
$82K Sell
976
-500
-34% -$35.5K 0.01% 469
2017
Q2
$96K Sell
1,476
-340
-19% -$23.1K 0.02% 181
2017
Q1
$136K Sell
1,816
-898
-33% -$59K 0.03% 136
2016
Q4
$159K Buy
+2,714
New +$143K 0.03% 133

Other funds holding ADNT

Zions Bancorporation's ADNT Position: Q1 2020 in Review

Zions Bancorporation sold out of Adient (ADNT) in Q1 2020, closing a stake of 695 shares — an estimated $15K sold.

Zions Bancorporation first reported a position in ADNT in Q4 2016 and held it in 13 quarters. The position peaked at $159K in Q4 2016. 285 funds tracked by Wall St. Rank hold ADNT as of Q1 2020.

  • Zions Bancorporation reported no remaining Adient position as of Q1 2020 after selling out during the quarter.
  • Zions Bancorporation sold 695 Adient shares in Q1 2020, an estimated $15K.
  • Zions Bancorporation first reported a position in Adient in Q4 2016 and held it in 13 quarters.
  • Zions Bancorporation's Adient position peaked at $159K in Q4 2016.
  • 285 funds tracked by Wall St. Rank held Adient as of Q1 2020.

Based on Zions Bancorporation's 13F filing for Q1 2020, filed 15 May 2020.